Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-02-04
DOI
10.1093/jac/dkab043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro efficacy of Imipenem-Relebactam and Cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
- (2020) L. Tselepis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections
- (2020) Jordan R. Smith et al. PHARMACOTHERAPY
- In Vitro Activity of the Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 against Carbapenem-Resistant Enterobacterales (CRE) With Varying Intrinsic and Acquired Resistance Mechanisms
- (2020) Kirk Nelson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam against Clinical Isolates of Gram-Negative Bacilli with Difficult-to-Treat Resistance and Multidrug-Resistant Phenotypes – SMART United States 2015-2017
- (2020) James A Karlowsky et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime-Avibactam Activity against a Challenge Set of Carbapenem-Resistant Enterobacterales: Ompk36 L3 Alterations and β-Lactamases with Ceftazidime Hydrolytic Activity Lead to Elevated MIC Values
- (2020) Mariana Castanheira et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment
- (2020) Irene Galani et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
- (2019) Christopher Fröhlich et al. mSphere
- Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018
- (2019) Alma Brolund et al. Eurosurveillance
- Activity of imipenem/relebactam against MDR Pseudomonas aeruginosa in Europe: SMART 2015–17
- (2019) Sibylle H Lob et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity
- (2019) Saoussen Oueslati et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of imipenem-relebactam and comparator agents against genetically characterized isolates of carbapenem-resistant Enterobacteriaceae
- (2019) Matthew C. Canver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
- (2019) Johann Motsch et al. CLINICAL INFECTIOUS DISEASES
- Activity of imipenem/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance
- (2019) Jessica Carpenter et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of imipenem/relebactam against a large collection of Pseudomonas aeruginosa clinical isolates and isogenic β-lactam resistant mutants
- (2019) Pablo Fraile-Ribot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Global Ascendency of OXA-48-Type Carbapenemases
- (2019) Johann D. D. Pitout et al. CLINICAL MICROBIOLOGY REVIEWS
- In vitro activity of ceftazidime/avibactam against isolates of carbapenem-non-susceptible Enterobacteriaceae collected during the INFORM global surveillance programme (2015–17)
- (2019) Iris Spiliopoulou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
- (2018) Jesús Rodríguez-Baño et al. CLINICAL MICROBIOLOGY REVIEWS
- Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads
- (2017) Ryan R. Wick et al. PLoS Computational Biology
- Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
- (2017) Ryan K. Shields et al. Open Forum Infectious Diseases
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2016) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones ofKlebsiella pneumoniaeST11/KPC-2, ST101/KPC-2 and ST512/KPC-3
- (2016) Jesús Oteo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees
- (2016) Ivica Letunic et al. NUCLEIC ACIDS RESEARCH
- Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods
- (2016) Chang-Ro Lee et al. Frontiers in Microbiology
- Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR, lon and rpsJ
- (2016) Li Fang et al. PLoS One
- Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals HighIn VitroSusceptibility to Colistin and Meropenem
- (2015) Jesús Oteo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Roary: rapid large-scale prokaryote pan genome analysis
- (2015) Andrew J. Page et al. BIOINFORMATICS
- The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae
- (2015) Amy J. Mathers et al. CLINICAL MICROBIOLOGY REVIEWS
- Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
- (2015) H. J. Morrill et al. Open Forum Infectious Diseases
- Prokka: rapid prokaryotic genome annotation
- (2014) T. Seemann BIOINFORMATICS
- RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
- (2014) Alexandros Stamatakis BIOINFORMATICS
- Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain
- (2014) Lorena López-Cerero et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013
- (2013) C Glasner et al. Eurosurveillance
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain
- (2012) E. Miró et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Identification of acquired antimicrobial resistance genes
- (2012) E. Zankari et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search